Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toralf Roch

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
European Journal of Immunology|January 18, 2021
Generation of HBsAg-reactive T- and B-cells following HBV vaccination in serological non-responders under hemodialysis treatmentToralf Roch, Claudia Giesecke-Thiel, Arturo Blazquez-Navarro, et al.
Plos One|July 13, 2017
Age dependent differences in the kinetics of γδ T cells after influenza vaccinationUlrik Stervbo, Dominika Pohlmann, Udo Baron, et al.
Kidney International|September 12, 2021
A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponseTimm H Westhoff, Felix S Seibert, Moritz Anft, et al.
European Journal of Immunology|April 7, 2011
Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitisElisabeth Calderón-Gómez, Vicky Lampropoulou, Ping Shen, et al.
Kidney International Reports|February 7, 2022
A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant RecipientsToralf Roch, Benjamin Rohn, Arturo Blazquez-Navarro, et al.
Immunity|November 25, 2010
Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infectionPatricia Neves, Vicky Lampropoulou, Elisabeth Calderon-Gomez, et al.
Frontiers in Transplantation|July 12, 2024
High incidence and viral load of HHV-6A in a multi-centre kidney transplant cohortArturo Blazquez-Navarro, Toralf Roch, Patrizia Wehler, et al.
Journal of Nephrology|December 2, 2022
Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivationArturo Blazquez-Navarro, Toralf Roch, Patrizia Wehler, et al.
Scientific Reports|November 12, 2020
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantationSharon Bajda, Arturo Blazquez-Navarro, Björn Samans, et al.
Scientific Reports|December 15, 2019
The TreaT-Assay: A Novel Urine-Derived Donor Kidney Cell-Based Assay for Prediction of Kidney Transplantation OutcomeConstantin J Thieme, Benjamin J D Weist, Annemarie Mueskes, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
European Journal of Immunology|January 18, 2021
Generation of HBsAg-reactive T- and B-cells following HBV vaccination in serological non-responders under hemodialysis treatmentToralf Roch, Claudia Giesecke-Thiel, Arturo Blazquez-Navarro, et al.
Plos One|July 13, 2017
Age dependent differences in the kinetics of γδ T cells after influenza vaccinationUlrik Stervbo, Dominika Pohlmann, Udo Baron, et al.
Kidney International|September 12, 2021
A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponseTimm H Westhoff, Felix S Seibert, Moritz Anft, et al.
European Journal of Immunology|April 7, 2011
Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitisElisabeth Calderón-Gómez, Vicky Lampropoulou, Ping Shen, et al.
Kidney International Reports|February 7, 2022
A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant RecipientsToralf Roch, Benjamin Rohn, Arturo Blazquez-Navarro, et al.
Immunity|November 25, 2010
Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infectionPatricia Neves, Vicky Lampropoulou, Elisabeth Calderon-Gomez, et al.
Frontiers in Transplantation|July 12, 2024
High incidence and viral load of HHV-6A in a multi-centre kidney transplant cohortArturo Blazquez-Navarro, Toralf Roch, Patrizia Wehler, et al.
Journal of Nephrology|December 2, 2022
Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivationArturo Blazquez-Navarro, Toralf Roch, Patrizia Wehler, et al.
Scientific Reports|November 12, 2020
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantationSharon Bajda, Arturo Blazquez-Navarro, Björn Samans, et al.
Scientific Reports|December 15, 2019
The TreaT-Assay: A Novel Urine-Derived Donor Kidney Cell-Based Assay for Prediction of Kidney Transplantation OutcomeConstantin J Thieme, Benjamin J D Weist, Annemarie Mueskes, et al.
Pageof 8